Systemic exertion intolerance disease associated to neuroendocrine dysfunction and cortical atrophy: a case report, 2022, Noé López-Amador

Discussion in 'ME/CFS research' started by Andy, Jun 1, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    22,311
    Location:
    Hampshire, UK
    Abstract

    Background
    Scarce evidence about the organic and functional abnormalities of systemic exertion intolerance disease (SEID) is found in literature and the pathophysiology is still unclear.

    Methods
    Following the CARE Guidelines, this case report describes a patient with a 5-year history of nonspecific symptoms, lately recognized as SEID.

    Results
    Low serum thyroid- and adrenocorticotropic stimulating hormone levels, and 24-h urinary cortisol excretion almost twice the upper limit were detected. Computed tomography scan found significant cortical atrophy. Low-dose modafinil improved the clinical outcome, added to nonpharmacologic approach.

    Conclusion
    To ascertain an accurate SEID diagnosis and treatment are a challenge in daily clinical practice, that must be engaged based in clear methods and good practice recommendations. Thus, family practitioners should be aware of this diagnosis.

    Paywall, https://academic.oup.com/fampra/advance-article-abstract/doi/10.1093/fampra/cmac060/6594429
     
    J.G, cfsandmore, DokaGirl and 2 others like this.

Share This Page